Company · CIK 0000749647 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Imunon, Inc. · IMNN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 AForm 4 → | Sep 15, 12:43 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 5,824 | $1.47 | $8,561 | 95,699 | — | |
| Sep 11, 2026 AForm 4 → | Sep 15, 12:42 pm EDT | Stacy LindborgPresident and CEO, Director | 5,504 | $1.47 | $8,091 | 105,580 | — | |
| Sep 11, 2026 AForm 4 → | Sep 15, 12:41 pm EDT | Douglas Vincent FallerChief Medical Officer | 4,211 | $1.47 | $6,190 | 41,288 | — | |
| Aug 31, 2026 SForm 4 → | Sep 1, 4:06 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,525 | $1.56 | $3,950 | 2,896 | −46.6% | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:10 pm EDT | Michael H TardugnoExecutive Chairman of Board, Director | 7,371 | $1.60 | $11,794 | 89,875 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:09 pm EDT | Stacy LindborgPresident and CEO, Director | 6,822 | $1.60 | $10,915 | 100,076 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:07 pm EDT | Douglas Vincent FallerChief Medical Officer | 3,626 | $1.60 | $5,802 | 37,077 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:06 pm EDT | Susan EylwardGeneral Counsel and Corp Sec | 2,525 | $1.60 | $4,040 | 5,421 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.